Considering forward projections from some pretty smart brokers, short interest, announcements of actual product rollout, current and pending distribution agreements, and FDA approval--I'm buying, little bits at a time but buying.
Proinvestor--that mule thing--oh you are a wit--I'll tell you what-- just us-- I say optr is higher 3 months from now, 6 months from now and at least 15 dollars or more a share 1 year from now. I miss any mark I never post again. I hit all three , you're gone and never darken our door again. No need for barbs back and forth, or conversation of any kind. Yes or no. In the mean time, we both shut up, let people who actually follow the news flow from this company do the posting of real information and stick it to one another when the future unfolds and the bets are won or lost........
News flash for you, I am very diligent about my investments (and shorts), and follow the miniscule details that most on this board to even bother looking at either through lazyness of their own or their own arrogance. I provide a service to this board and will contine to do so, and at the same time watching my short postions increase in value....LOL!
I agree with this view, but what's hard to understand is why this company is barely trading higher than it was in either 2007 or 2009 when difficid was not approved. There must be something about the company that has disappointed the street. Was is the terms of the deal with astellas or cubist? Otherwise, it doesn't make any sense. Any other views?